Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112
Dong Dong,1* Xiao Wang,1* Huailing Wang,1 Xingwang Zhang,2 Yifei Wang,1 Baojian Wu2 1Guangzhou Jinan Biomedicine Research and Development Center, 2Division of Pharmaceutics, College of Pharmacy, Jinan University, Guangzhou, People’s Republic of China *These authors contributed equally to...
Main Authors: | Dong D, Wang X, Wang H, Zhang X, Wang Y, Wu B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-03-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/elucidating-the-in-vivo-fate-of-nanocrystals-using-a-physiologically-b-peer-reviewed-article-IJN |
Similar Items
-
Silence of STAT3 Enhances SNX-2112-induced Apoptosis of Esophageal Cancer Stem Cells
by: XU Dandan, et al.
Published: (2019-03-01) -
Suppression of Esophageal Cancer Stem-like Cells by SNX-2112 Is Enhanced by STAT3 Silencing
by: Dan-dan Xu, et al.
Published: (2020-12-01) -
Complex Crystal Structure Determination and in vitro Anti–non–small Cell Lung Cancer Activity of Hsp90N Inhibitor SNX-2112
by: Dong Zhao, et al.
Published: (2021-03-01) -
2112 Starburst MR venography
by: Koktzoglou Ioannis, et al.
Published: (2008-10-01) -
Mechanisms by which SNX-BAR subfamily controls the fate of SNXs’ cargo
by: Yaolin Long, et al.
Published: (2025-03-01)